LGBT Cancer Project

Ovarian Cancer Clinical Trials

A listing of Ovarian Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Alabaster Alabama 35007

A Phase 3 clinical study for patients with Ovarian Cancer

Bessemer Alabama 35022

A Phase 3 clinical study for patients with Ovarian Cancer

Birmingham Alabama 35249

A Phase 1 clinical study for patients with Neoplasms

Birmingham Alabama 35233

A Phase 1 clinical study for patients with Neoplasms

Birmingham Alabama 35211

A Phase 3 clinical study for patients with Ovarian Cancer

Birmingham Alabama 35243

A Phase 3 clinical study for patients with Ovarian Cancer

Birmingham Alabama 35209

A Phase 3 clinical study for patients with Ovarian Cancer

Birmingham Alabama 35235

A Phase 3 clinical study for patients with Ovarian Cancer

Birmingham Alabama 35205

A Phase 3 clinical study for patients with Ovarian Cancer

Birmingham Alabama 35294-3300

Patients are needed to participate in a clinical research study evaluating INCB057643 for the treatment of Advanced Cancer

Birmingham Alabama 35294

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

Mobile Alabama 36604

A Phase 2 clinical study for patients with Advanced Gynecological Cancers, Ovarian Cancer, Cervical Cancer or Uterine Cancer

Muscle Shoals Alabama 35661

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Alaska

UPDATED

Anchorage Alaska 99508

Patients are needed to participate in a clinical research study evaluating cediranib and olaparib for the treatment of Recurrent Platinum Resistant Ovarian Cancer

Arizona

Arizona Oncology Associates
Phoenix Arizona

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Arizona Oncology Associates
Tucson Arizona

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Research Center
Tucson Arizona

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Niraparib Maintenance Treatment in Patients with Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

Chandler Arizona

A clinical trial to evaluate treatments using Niraparib for patients with Ovarian Cancer

Chandler Arizona 85224

A Phase 3 clinical study for patients with Ovarian Cancer, Platinum Resistant/Refractory Ovarian Cancer

Goodyear Arizona 85338

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Phoenix Arizona

A clinical trial to evaluate treatments using Niraparib for patients with Ovarian Cancer

Phoenix Arizona 85004

A Phase 3 clinical study for patients with Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer or Ovarian Cancer

Phoenix Arizona 85027

A Phase 3 clinical study for patients with Ovarian Cancer

Phoenix Arizona 85016

A Phase 3 clinical study for patients with Ovarian Cancer

Phoenix Arizona 85016

A Phase 3 clinical study for patients with Ovarian Cancer, Platinum Resistant/Refractory Ovarian Cancer

Phoenix Arizona 85027

A Phase 3 clinical study for patients with Ovarian Cancer, Platinum Resistant/Refractory Ovarian Cancer

Scottsdale Arizona 85259

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Scottsdale Arizona 85258

A Phase 1 clinical study for patients with Advance Solid Tumors

Scottsdale Arizona 85258

A Phase 1 clinical study for patients with Neoplasms

Scottsdale Arizona 85258

A Phase 1 clinical study for patients with Neoplasms

Scottsdale Arizona 85258

A Phase 3 clinical study for patients with Ovarian Cancer

Scottsdale Arizona 85258

A Phase 3 clinical study for patients with Ovarian Cancer, Platinum Resistant/Refractory Ovarian Cancer

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating CRS-207 and epacadostat (INCB024360) for the treatment of Platinum-resistant Ovarian Cancer, Platinum-resistant Fallopian Cancer or Platinum-resistant Peritoneal Cancer

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating Ferumoxytol followed by MM-398

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study of AZD1775 to evaluate Locally Advanced Solid Tumors or Metastatic Solid Tumors

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study of FPA008 and Nivolumab, Selected Advanced Cancers

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study of MM-310

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

Tempe Arizona 85284

A Phase 3 clinical study for patients with Ovarian Cancer

Tucson Arizona

A clinical trial to evaluate treatments using Chemotherapy and Rucaparib for patients with Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Tucson Arizona

A clinical trial to evaluate treatments using Niraparib for patients with Ovarian Cancer

Tucson Arizona 85711

A Phase 3 clinical study for patients with Ovarian Cancer

Tucson Arizona 85704

A Phase 3 clinical study for patients with Ovarian Cancer

Tucson Arizona 85711

A Phase 3 clinical study for patients with Ovarian Cancer, Platinum Resistant/Refractory Ovarian Cancer

Tucson Arizona 85704

A Phase 3 clinical study for patients with Ovarian Cancer, Platinum Resistant/Refractory Ovarian Cancer

Tucson Arizona

Patients are needed to participate in a clinical research study of Niraparib and Placebo to evaluate Ovarian Cancer

Arkansas

Fayetteville Arkansas 72703

A Phase 3 clinical study for patients with Ovarian Cancer